首页 产品目录 分子砌块 按官能团 酯类 ((3aR,4S,6Z,9S,11E,12aR)-11-甲基-3-亚甲基-2,7-二氧代-2,3,3a,4,5,9,10,12a-八氢-7H-6,9-亚甲基呋喃并[2,3-f][1]氧杂环十一碳烯-4-基)(Z)-2-甲基丁-2-烯酸酯

((3aR,4S,6Z,9S,11E,12aR)-11-甲基-3-亚甲基-2,7-二氧代-2,3,3a,4,5,9,10,12a-八氢-7H-6,9-亚甲基呋喃并[2,3-f][1]氧杂环十一碳烯-4-基)(Z)-2-甲基丁-2-烯酸酯

(3aR,4S,6Z,9S,11E,12aR)-11-methyl-3-methylene-2,7-dioxo-2,3,3a,4,5,9,10,12a-octahydro-7H-6,9-(metheno)furo[2,3-f][1]oxacycloundecin-4-yl (Z)-2-methylbut-2-enoate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 95% 询价
- +
5mg 95% 询价
- +
10mg 95% 询价
- +
25mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

185213-52-9

中文名称

((3aR,4S,6Z,9S,11E,12aR)-11-甲基-3-亚甲基-2,7-二氧代-2,3,3a,4,5,9,10,12a-八氢-7H-6,9-亚甲基呋喃并[2,3-f][1]氧杂环十一碳烯-4-基)(Z)-2-甲基丁-2-烯酸酯

英文名称

(3aR,4S,6Z,9S,11E,12aR)-11-methyl-3-methylene-2,7-dioxo-2,3,3a,4,5,9,10,12a-octahydro-7H-6,9-(metheno)furo[2,3-f][1]oxacycloundecin-4-yl (Z)-2-methylbut-2-enoate

别名

Scabertopin;Gpr52 antagonist E7 (Scabertopin);2-Butenoic acid, 2-methyl-, (3aR,4S,9S,11E,12aR)-2,3,3a,4,5,9,10,12a-octahydro-11-methyl-3-methylene-2,7-dioxo-7H-9,6-methenofuro[2,3-f]oxacycloundecin-4-yl ester, (2Z)-;Scabertopin, 10 mM in DMSO

标准英文名

(3aR,4S,6Z,9S,11E,12aR)-11-methyl-3-methylene-2,7-dioxo-2,3,3a,4,5,9,10,12a-octahydro-7H-6,9-(metheno)furo[2,3-f][1]oxacycloundecin-4-yl (Z)-2-methylbut-2-enoate

MDL No.

-

分子式

C20H22O6

分子量

358.39

精确分子量

358.14

SMILES

C=C1C(=O)O[C@@H]2/C=C(\C)C[C@H]3C=C(C[C@H](OC(=O)/C(C)=C\C)[C@@H]12)C(=O)O3

标准SMILES

C/C=C(/C)\C(=O)O[C@H]1CC2=C[C@H](CC(C)=C[C@H]3OC(=O)C(=C)[C@H]13)OC2=O

用途

Antitumor activity; inhibits proliferation of various tumor cells; delays papilloma formation and reduces average number of papillomas and average body weight of papilloma-bearing mice when applied topically (100 mg/kg); significantly suppresses soft tissue tumor induced by subcutaneous injection of 20-methylcholanthrene (20-MCA) following intraperitoneal administration; reduces sarcoma incidence and tumor diameter compared to 20-MCA-induced control group; markedly inhibits solid tumor growth of Dalton’s lymphoma ascites (DLA) and Ehrlich ascites carcinoma (EAC) cells after intraperitoneal administration, and prolongs survival time of tumor-bearing mice.

InChIKey

FTPHYXGWMIZVMP-RZYABJHASA-N

安全信息

SureRoute逆合成路线

1.  185213-52-9 逆合成路线 1

—
—
—
—
ACITXF224
185213-52-9
来源: SureRoute

2.  185213-52-9 逆合成路线 2

ACWQAK254
565-63-9
—
—
ACITXF224
185213-52-9
来源: SureRoute

3.  185213-52-9 逆合成路线 3

—
—
—
—
ACITXF224
185213-52-9
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手